Tokiko Nagamura-Inoue

Last updated: May 2, 2019 at 15:32

Name	Tokiko Nagamura-Inoue

Research Interests

Ba(1) , TF1(1) , GM-CSF(4) , F3(1) , VSEL(1)

Research Areas

Basic medicine / General medical chemistry /
Clinical internal medicine / Embryonic/Neonatal medicine /
Clinical internal medicine / Hematology /
Boundary medicine / Applied pharmacology /

Published Papers

Plain Text1 2 3 4 >

Adverse Events Associated With Infusion of Hematopoietic Stem Cell Products: A Prospective and Multicenter Surveillance Study.

Ikeda K, Ohto H, Okuyama Y, Yamada-Fujiwara M, Kanamori H, Fujiwara SI, Muroi K, Mori T, Kasama K, Iseki T, Nagamura-Inoue T, Fujii N, Ashida T, Kameda K, Kanda J, Hirose A, Takahashi T, Nagai K, Minakawa K, Tanosaki R

Transfusion medicine reviews Jun 2018 [Refereed]

Prognostic impact of circulating tumor DNA status post-allogeneic hematopoietic stem cell transplantation in AML and MDS.

Nakamura S, Yokoyama K, Shimizu E, Yusa N, Kondoh K, Ogawa M, Takei T, Kobayashi A, Ito M, Isobe M, Konuma T, Kato S, Kasajima R, Wada Y, Nagamura-Inoue T, Yamaguchi R, Takahashi S, Imoto S, Miyano S, Tojo A

Blood Apr 2019 [Refereed]

Circulating tumor DNA dynamically predicts response and/or relapse in patients with hematological malignancies.

Nakamura S, Yokoyama K, Yusa N, Ogawa M, Takei T, Kobayashi A, Ito M, Shimizu E, Kasajima R, Wada Y, Yamaguchi R, Imoto S, Nagamura-Inoue T, Miyano S, Tojo A

International journal of hematology 108(4) 402-410 Jun 2018 [Refereed]

Cytokine Profile in Sweet's Syndrome under the Treatment of Pulmonary Toxoplasmosis Complicated with Myelodysplastic Syndrome.

Matsuzawa Y, Adachi E, Takahashi A, Sato H, Lim LA, Komatsu T, Koibuchi T, Nagamura-Inoue T, Tojo A, Nagayama H, Yotsuyanagi H

Internal medicine (Tokyo, Japan) Mar 2019 [Refereed]

Alloimmune hemolysis due to major RhE incompatibility after unrelated cord blood transplantation.

Isobe M, Konuma T, Abe-Wada Y, Hirata K, Ogami K, Kato S, Oiwa-Monna M, Tanoue S, Nagamura-Inoue T, Takahashi S, Tojo A

Leukemia & lymphoma 59(4) 1000-1003 Apr 2018 [Refereed]

Mesenchymal stromal cells as a potential therapeutic for neurological disorders.

Mukai T, Tojo A, Nagamura-Inoue T

Regenerative therapy 9 32-37 Dec 2018 [Refereed]

Dose-Dependent Effect of Intravenous Administration of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Neonatal Stroke Mice.

Tanaka E, Ogawa Y, Mukai T, Sato Y, Hamazaki T, Nagamura-Inoue T, Harada-Shiba M, Shintaku H, Tsuji M

Frontiers in neurology 9 133 2018 [Refereed]

Umbilical Cord-Derived Mesenchymal Stromal Cells Contribute to Neuroprotection in Neonatal Cortical Neurons Damaged by Oxygen-Glucose Deprivation.

Mukai T, Tojo A, Nagamura-Inoue T

Frontiers in neurology 9 466 2018 [Refereed]

Clinical impact of pretransplant use of multiple tyrosine kinase inhibitors on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia.

Kondo T, Nagamura-Inoue T, Tojo A, Nagamura F, Uchida N, Nakamae H, Fukuda T, Mori T, Yano S, Kurokawa M, Ueno H, Kanamori H, Hashimoto H, Onizuka M, Takanashi M, Ichinohe T, Atsuta Y, Ohashi K

American journal of hematology 92(9) 902-908 Sep 2017 [Refereed]

Intravenous injection of umbilical cord-derived mesenchymal stromal cells attenuates reactive gliosis and hypomyelination in a neonatal intraventricular hemorrhage model.

Mukai T, Mori Y, Shimazu T, Takahashi A, Tsunoda H, Yamaguchi S, Kiryu S, Tojo A, Nagamura-Inoue T

Neuroscience 355 175-187 Jul 2017 [Refereed]